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Background: Despite continuous advances in diagnosis and therapy, oral cancers are mostly diagnosed at ad-
vanced stages with minor survival improvements in the last two decades. Both phenomena have been attributed to 
delays in the diagnosis. This study aims at quantifying the time elapsed until definitive diagnosis in these patients 
and the patient interval’s contribution.
Material and Methods: A hospital-based, ambispective, observational study was undertaken on incident cases 
with a pathological diagnosis of oral squamous cell carcinoma recruited during 2015 at the Oral and Maxillofacial 
Surgery services of CHUAC (A Coruña) and POVISA (Vigo) hospitals. 
Results: 74 consecutive oral cancer patients (59.5% males; median age: 65.0 years (IQ:57-74)) were studied. Most 
cases (52.7%; n=39) were at advanced stages (TNM III-IV) at diagnosis.
The period since first sign/symptom until the patient seeks health care was the longest interval in the pathway to 
diagnosis and treatment (median: 31.5 days; IQR= 7.0 – 61.0) and represents >60% of the interval since symptom 
onset until referral to specialised care (pre-referral interval). The average interval assigned to the patient resulted 
to be relatively larger than the time elapsed since the patient is seen at primary care until a definitive diagnosis is 
reached (diagnostic interval). Median of the referral interval for primary care professionals: 6.5 days (IQR= 0.0 – 
49.2) and accounts for 35% (19% - 51%) of the diagnostic interval. 
Conclusions: The patient interval is the main component of the pathway to treatment since the detection of a 
bodily change until the definitive diagnosis. Therefore, strategies focused on risk groups to shorten this interval 
should be implemented in order to ease an early diagnosis of symptomatic oral cancer.
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Introduction
Despite the continuous advances in the fields of diagno-
sis and therapy, oral cancers are still diagnosed mostly 
at advanced stages (III-IV) and the improvements in 
terms of patient survival have been very minor (5%) 
in the last two decades (1,2). Both phenomena have 
been put down to delays in the diagnosis of the disease 
(3,4). This hypothesis has been confirmed by different 
meta-analitical studies which unveiled the relationship 
between diagnostic delay and advanced disease (5) and 
a moderate impact on survival to head and neck carci-
nomas (6).
For over 75 years the culpability for this delay has been 
attributed either to the patient or both to patients and 
physicians (7). In the particular case of oral cancer, some 
methodologically heterogeneous studies using a range of 
different arbitrary criteria to disclose delayed cases have 
identified the patient, the clinician, and the health system 
to be responsible for the delays in diagnosis (8,9).
This overall diagnostic delay (period elapsed between 
the first symptom or sign and the definitive histologi-
cal diagnosis) has been extensively studied by several 
research groups that have independently identified vari-
ous time lapses with a potential role in delayed diagno-
ses, namely patient delay, scheduling delay or primary 
care delay, appointment delay (specliased care diagnos-
tic interval), and medical specialist delay (10-12). All 
these reports based upon the idea of apportioning blame 
for diagnostic delay, -putting aside their hypothetical le-
gal consequences- have proved unable both to monitor 
the process until the final diagnosis of symptomatic oral 
cancer and to render consistent and reliable results (8).
In an attempt to ease comparability among studies and 
to standardise the key points (time intervals since de-
tection of a bodily change until treatment is started), 
the use of the research model “model of pathways to 
treatment” has been encouraged together with a specific 
methodology aimed at minimising potential biases (13). 
Recently, a systematic review has identified the actual 
periods where a delay may be found in the particular 
path of a patient with symptomatic oral cancer (14). 
Also, the use of term “diagnostic delay” is not recom-
mended for research on this topic (13,14).
Despite information on the aforementioned topics would 
be paramount to identify targets for intervention when 
pursuing an early oral cancer diagnosis, there are no re-
ports quantifying the relative contribution of these time 
intervals to the time to diagnosis designed within the 
consensus theoretical framework (The Aarhus State-
ment Model) (13).
Therefore, the aim of this investigation was to quantify 
the time intervals elapsed until definitive diagnosis in 
patients suffering from symptomatic oral cancer, as 
well as to assess the relative length of the patient inter-
val in terms of overall diagnostic delay.
Material and Methods
A hospital-based, ambispective, observational study 
was undertaken where the prospective component starts 
at the moment of the patient’s first contact with the spe-
cialist who will be treating his/her disease. The subjects 
of the study were incident cases with a pathologically 
confirmed diagnosis of oral squamous cell carcinoma 
(OSCC) recruited during 2015 at the Oral and Maxil-
lofacial Surgery services of CHUAC (A Coruña) and 
POVISA (Vigo) hospitals. These hospitals serve a total 
of 356 primary care centres in Galicia (North-western 
Spain). The exclusion criteria were: prevalent/recurrent 
cases, second primary tumours, multiple carcinomas, or 
patients treated at hospitals outside of the public health 
service network.
The model of pathways to treatment was chosen to es-
tablish the time intervals since the detection of a bodily 
change to the definitive (pathological) diagnosis of oral 
squamous cell carcinoma (13-15). The patient-related 
interval, together with the primary care and diagnostic 
intervals were also considered, as well as their relative 
contribution to the overall time to definitive diagnosis. 
In order to minimise memory bias, particularly those re-
lated to the date of first symptoms detection and date of 
first presentation, patient self-reported information was 
checked against patient’s relatives and clinical records 
both at primary care and hospital levels. Relevant dates 
were obtained from the patient by means of a structured, 
face-to-face conversation with the surgeon as part of the 
routine clinical interview for hospital records.
Definition of intervals: In compliance with the Aarhus 
Statement (13,14), we considered the time intervals 
outlined by the following events: bodily change (sign/
symptom onset), first seen at primary care level, referral 
for specialised care, and definitive diagnosis. Addition-
al time lapses identified as potential sources of patient 
delay (10,11,13), and appointment delay (14,16) were 
also studied. A pre-referral interval (16) (patient inter-
val + primary care interval), a diagnostic interval (16) 
(time from first seen in primary care to definitive di-
agnosis), and a total diagnostic interval (14,16,17) were 
also calculated (Fig. 1). Participants gave their informed 
consent before entering the study, which was approved 
by the relevant committee of ethics in research (No. 
2014/604).
- Statistical analysis
Statistical analysis was undertaken using the SPSS+ 15.0 
statistical package (Chicago, IL, USA). The mean and the 
median (Md) were used as central trend statistics, and the 
interquartile range and the 90th centile as spread indica-
tors, when describing the time intervals (days). The ratio 
between means and medians of patient interval to pri-
mary care interval, to pre-referral interval, to diagnostic 
interval, and to total diagnostic interval were also calcu-
lated, assuming the conditions for using the test.
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Results
A convenience sample of 74 OSCC patients (59.5% 
males; median age: 65.0 years (IQ:57-74)) was stud-
ied. The most frequently affected sites were the tongue 
(n=38; 51.4%) and the palate (n=10; 13.5%), followed by 
the floor of the mouth and gingiva (n=4; 5.4%). Other 
locations, altogether, account for 23% of the sample 
(n=17). Most cases (52.7%; n=39) were at advanced 
stages (TNM III-IV) at the time of diagnosis.
The period since the first cancer-related sign/symptom 
is detected until the patient demands an appointment at 
primary care resulted to be the longest interval in the 
subject’s pathway to diagnosis and treatment (median: 
31.5 days; IQR= 7.0 – 61.0) and accounts for more than 
60% of the interval since the symptoms onset until the 
patient is referred for specialised care (pre-referral in-
terval). Besides, the average interval assigned to the 
patient resulted to be relatively larger than the time 
elapsed since the patient is seen at primary care until a 
definitive diagnosis is reached (diagnostic interval). The 
referral interval assigned to primary care professionals 
(dentists and/or physicians) elicited a median of 6.5 days 
(IQR= 0.0 – 49.2) and accounts for 35% (19% - 51%) 
of the average diagnostic interval.  The other intervals 
in the pathway to diagnosis analysed in this study have 
been significantly shorter: the specialist interval (oral 
and maxillofacial surgeon) showed a median of 6.0 
days (IQR= 4.0 – 11.25); the intervals of appointment 
and scheduling at primary care (median: 1.5 days; IQR= 
0.00 – 8.5) and at a specialised level (median: 1.5 days; 
IQR= 6.0 – 17.5) were not relevant in terms of the over-
all time to diagnosis (Tables 1,2).
Discussion
This study is the first investigation reporting quanti-
tative data on each of the time intervals symptomatic 
OSCC patients go through to reach a definitive diagno-
sis, according to the “model of pathways to treatment” 
(13). Although this model would permit prioritisation of 
interventions for early diagnosis, there are some limita-
tions in our research that have to be taken into account, 
mostly linked to the sample itself and to the fact it is a 
hospital-based study. On the other hand, a selection bias 
is highly unlikely due to the absence of drop-outs, and 
also because the features of the sample are not different 
from the general characteristics of cancer patients at di-
Fig 1. Adaptation of the pathways to treatment model to the particularities of oral cancer.
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agnosis (1). The main strengths of our study rely on the 
use of the guidelines for improving design and report-
ing studies in early cancer diagnosis (Aarhus statement) 
(13), with clearly defined start- and endpoints within the 
theoretical framework in a prospective design, which 
increases the quality of the data collected. Moreover, 
and to prevent a potential recall bias, the information 
provided by the patients were double-checked against 
patient’s relatives and clinical records at both primary 
and specialised care levels.
In our series, total diagnostic delay has shown values 
close to the reported from Japan (24), and shorter time 
intervals than those reported from Iran (20). In this 
sense, the total pre-treatment interval found in out study 
resulted to be markedly lower than reported by a nar-
rative review summarizing data from patients in Ger-
many, UK, and USA, where values ranging from 5 to 6 
months or longer were recorded (8).
Assuming that large intervals to treatment result in poor 
outcomes it is paramount to know the relative contribu-
tion of each individual interval to the whole process of 
reaching treatment (total pre-treatment interval) in or-
der to target potential interventions (13,14).
In this sense, the analysis of the patient-related delay 
(classically defined as “patient diagnostic delay”) has 
produced equivocal results (8,9): different papers pu-
blished in the last decade report a median <1.5 months 
(18,19), whereas other groups described much longer 
intervals (20), ranging from 3.5 to 4 months where 
the patient delay prevails over the professional and 
health-system delays (8). This circumstance may well 
be explained by the lack of specificity of the signs and 
symptoms of OSCC, the difficulty in identifying certain 
symptoms considered as potentially dangerous (12), and 
also by the differences in socio-cultural environments 
which condition symptom interpretation and become 
determinants linked to longer patient intervals (22).
Our results show a median of the patient interval of 31.5 
days, very close to the 30 days reported by the National 
Audit of Cancer Diagnosis in Primary Care (UK) and 
also to other reported series from Finland, which share 
similar socio-economic contexts despite the evident 
geographical disparities (16,18,19). The patient inter-
val depends greatly on tumour site, and patients with 
oropharyngeal, laryngeal, oesophageal, and neck carci-
nomas show the longest patient intervals (16).
Cancer diagnosis Mean (95%CI) Median (95% CI)
Patient interval/Primary care interval (Referral interval) 5.12 (0.99-11.25) 1.25 (0.05- 7.71)
Patient interval/overall pre-referral interval 0.61 (0.43-0.78) 0.70 (0.26-0.96)
Patient interval/Diagnostic interval 1.91 (0.89-3.02) 0.79 (0.33-3.1)
Patient interval/Total diagnostic interval 0.40 (0.27-0.53) 0.37 (0.14-0.65)
Patient interval/Pre-treatment interval 0.30 (0.18-0.42) 0.26 (0.07-0.41)
Time intervals (days) Mean 25th 50 th 75 th 90 th
Patient interval 45.86 7.00 31.50 61.00 121.40
Primary care. Scheduling interval 8.00 0.00 1.50 8.50 19.10
Primary care. Referral interval 29.08 0.00 6.50 49.25 74.00
Pre-referral interval 83.61 39.00 66.50 129.00 168.90
Specialized care. Scheduling interval 13.84 6.00 1.50 17.50 49.20
Specialist interval 11.54 4.00 6.00 11.25 22.60
Diagnostic Interval 63.20 12.00 36.00 86.00 133.00
Total diagnostic interval 103.23 35.50 86.00 146.25 195.60
Pre-treatment interval 28.75 14.25 22.00 33.00 49.00
Total pre-treatment interval 130.80 61.75 103.00 176.00 246.50
Table 1. Time intervals (days) in the sample until treatment is started.
Table 2. Mean – median ratio of the patient interval over other time intervals.
(mean or median values >1 indicate longer patient interval when compared to other intervals).
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Bearing in mind that a longer pre-referral interval (pa-
tient + primary care interval) is a risk factor for ad-
vanced disease and mortality from oral cancer (6) it is 
fundamental to know the relative length of both inter-
vals. Our study has shown a clear predominance of the 
patient interval over that of the primary care profes-
sional, as has been previously described for other sites 
(melanoma, breast, testicular, vulval, cervical, and la-
ryngeal carcinomas) (16).
The primary care interval is quite stable for each loca-
tion, and it is related to the number of consultations at 
the primary care level. This interval tends to be shorter 
for those neoplasms showing visible or palpable lesions, 
such as breast, endometrium, and vulva (16). The pri-
mary care interval in our series (Md=6.5 days) is very 
similar to those reported by other oral cancer series (11, 
24) and close to the ones reported for thyroid and laryn-
geal cancers (16). However, despite oral cancer is con-
sidered a carcinoma “easy-to suspect” after presentation 
in primary care, where early signs such as changes in 
colour and texture or event the presence of precursor le-
sions (DOPM) (21) are clear warning clues, some series 
have reported large primary care intervals with means 
and medians about one month (25) or even longer (1.9 
months) in India (26).
Several contributing factors, like system factors (health 
care policy) and patient factors often act together in dif-
ferent time intervals, as occurs at the primary care and 
the specialised care scheduling intervals, with a median 
of just 1.5 days in our series. This is relevant, as the pri-
mary care scheduling interval has been classically com-
puted as “patient delay” although it is also conditioned 
by the availability and accessibility of the healthcare 
system (8).
-Practical implications for research and health policy
In order to avoid terminological inconsistencies and to 
ease comparisons between studies on early cancer diag-
nosis, it is strongly recommended to follow the criteria 
of the Aarhus Statement guidelines. The adaptation of 
the “pathways to treatment” depicted in figure 1 may be 
useful for this purpose. 
The patient interval is the main component of the to-
tal diagnostic interval, and it is proportionally larger 
than the interval assigned to Primary Care, and even 
longer than the diagnostic interval (from the first con-
sultation at primary care level to definitive diagnosis). 
Paradoxically, a great number of interventions aimed at 
increasing oral cancer knowledge among general den-
tists and physicians have been undertaken to shorten 
the patient’s referral period to specialised care, but oral 
cancer patient-centered interventions are very scarce 
(27,28). Actually, patients are the principal target for in-
terventions, which should be focused at increasing pub-
lic awareness of the disease. In this sense, and despite 
the reported transitory effects, mass media information 
campaigns (radio and television, newspapers, Internet, 
and even advertisements on billboards) offer oppor-
tunities for saving lives and may be useful for raising 
cancer awareness. However, only information leaflets 
have proved a significant effect on raising the long-term 
oral cancer knowledge and demonstrated a subsequent 
impact on disease awareness among the public (28). 
Besides, it should be taken into account that oral can-
cer awareness is particularly deficient among high-risk 
groups and those with lower socio-economic status, and 
also that community-based educational interventions 
have demonstrated poor effectivity (28), perhaps due to 
a poor adaptation to the socio-cultural context of at-risk 
population. 
Our results also show a margin for improvement in 
the diagnostic interval, where some advantages can be 
taken from previous experiences. Thus, interventions 
aimed at diminishing the primary care interval (such as 
the NICE guidelines) have proved effective in reducing 
the diagnostic interval for head and neck carcinomas 
(29). In the same way, an adequate prioritisation of pa-
tients with head and neck carcinomas has been able to 
significantly shorten the interval from referral to treat-
ment (30).
Conclusions
The patient interval is the main component of the path-
way to treatment since the detection of a bodily change 
until the definitive diagnosis. Therefore, strategies fo-
cused on risk groups to shorten this interval should 
be implemented in order to ease an early diagnosis of 
symptomatic oral cancer.
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